Publications by authors named "N Donner-Banzhoff"
Background: Rising costs are a challenge for healthcare systems. To keep expenditure for drugs under control, in many healthcare systems, drug prescribing is continuously monitored. The Bavarian Drug Agreement (German: Wirkstoffvereinbarung or WSV) for the ambulatory sector in Bavaria (the federal state of Germany) was developed for this purpose.
View Article and Find Full Text PDFBackground: Chronic ischemic heart disease (IHD) is one of the leading causes of morbidity and mortality. Physical activity (PA) is an effective secondary preventive strategy in IHD management. The German treatment guideline recommends that general practitioners (GPs) deliver PA advice to patients.
View Article and Find Full Text PDFBackground And Objectives: Many past studies have focused on uncertainty in medical practice, yet it is still not well understood in the field of family medicine, especially among residents. The aim of this study was to examine situations in which residents experience uncertainty and the coping strategies they use to deal with it. The results may have implications for advanced training programs and the specialist training in family medicine.
View Article and Find Full Text PDFControlling Prescribing through "Preferred Drug" Targets-The Bavarian Experience.
Int J Environ Res Public Health
September 2024
Article Synopsis
- The Bavarian Drug Agreement aims to manage rising drug costs by setting prescribing targets for preferred and generic medications, with healthcare providers receiving feedback and facing potential penalties based on their performance.
- Analysis of prescribing data from early 2018 showed that while high-volume drug targets are generally met, many less common targets are often missed, particularly in pediatric care.
- Generic drugs tend to be prescribed more effectively than recommended medications, as prescribers struggle with new, expensive options that may provide unclear benefits, leading to challenges in meeting targets.